65 related articles for article (PubMed ID: 14592838)
1. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation.
Chiocchetti A; Indelicato M; Bensi T; Mesturini R; Giordano M; Sametti S; Castelli L; Bottarel F; Mazzarino MC; Garbarini L; Giacopelli F; Valesini G; Santoro C; Dianzani I; Ramenghi U; Dianzani U
Blood; 2004 Feb; 103(4):1376-82. PubMed ID: 14592838
[TBL] [Abstract][Full Text] [Related]
2. An integrin axis induces IFN-β production in plasmacytoid dendritic cells.
Simoes DCM; Paschalidis N; Kourepini E; Panoutsakopoulou V
J Cell Biol; 2022 Sep; 221(9):. PubMed ID: 35878016
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin in autoimmune disorders: current knowledge and future perspective.
Xu C; Wu Y; Liu N
Inflammopharmacology; 2022 Apr; 30(2):385-396. PubMed ID: 35235108
[TBL] [Abstract][Full Text] [Related]
4. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
5. High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection.
Cappellano G; Abreu H; Raineri D; Scotti L; Castello L; Vaschetto R; Chiocchetti A
EMBO Mol Med; 2021 May; 13(5):e14124. PubMed ID: 33787012
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin as a candidate of therapeutic application for the acute brain injury.
Zhou Y; Yao Y; Sheng L; Zhang J; Zhang JH; Shao A
J Cell Mol Med; 2020 Aug; 24(16):8918-8929. PubMed ID: 32657030
[TBL] [Abstract][Full Text] [Related]
7. Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis.
Juge PA; Gazal S; Constantin A; Mariette X; Combe B; Tebib J; Dougados M; Sibilia J; Le Loet X; Dieudé P
RMD Open; 2017; 3(2):e000448. PubMed ID: 29071117
[TBL] [Abstract][Full Text] [Related]
8. Myelopoiesis embraces its inner weakness.
Gerlic M; Croker BA
Nat Immunol; 2017 Aug; 18(9):953-954. PubMed ID: 28829446
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin at the Crossroads of Inflammation and Tumor Progression.
Castello LM; Raineri D; Salmi L; Clemente N; Vaschetto R; Quaglia M; Garzaro M; Gentilli S; Navalesi P; Cantaluppi V; Dianzani U; Aspesi A; Chiocchetti A
Mediators Inflamm; 2017; 2017():4049098. PubMed ID: 28769537
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.
Clemente N; Raineri D; Cappellano G; Boggio E; Favero F; Soluri MF; Dianzani C; Comi C; Dianzani U; Chiocchetti A
J Immunol Res; 2016; 2016():7675437. PubMed ID: 28097158
[TBL] [Abstract][Full Text] [Related]
11. Association between
Xiao X; Dong Z; Ye X; Yan Y; Chen X; Pan Q; Xie Y; Xie J; Wang Q; Yuan Q
Biomed Rep; 2016 Sep; 5(3):321-326. PubMed ID: 27602211
[TBL] [Abstract][Full Text] [Related]
12. Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.
Boggio E; Dianzani C; Gigliotti CL; Soluri MF; Clemente N; Cappellano G; Toth E; Raineri D; Ferrara B; Comi C; Dianzani U; Chiocchetti A
J Immunol Res; 2016; 2016():9345495. PubMed ID: 27478856
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.
Kornegay JN; Spurney CF; Nghiem PP; Brinkmeyer-Langford CL; Hoffman EP; Nagaraju K
ILAR J; 2014; 55(1):119-49. PubMed ID: 24936034
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients.
Quaglia M; Chiocchetti A; Cena T; Musetti C; Monti S; Clemente N; Dianzani U; Magnani C; Stratta P
Clin Rheumatol; 2014 Sep; 33(9):1263-71. PubMed ID: 24820147
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gender differences in genetic risk: association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population.
Kadota K; Mori M; Yanagimachi M; Miyamae T; Hara T; Kanetaka T; Nozawa T; Kikuchi M; Hara R; Imagawa T; Kaneko T; Yokota S
PLoS One; 2013; 8(8):e72551. PubMed ID: 24023622
[TBL] [Abstract][Full Text] [Related]
16. Anti-cytokine autoantibodies in autoimmune diseases.
Cappellano G; Orilieri E; Woldetsadik AD; Boggio E; Soluri MF; Comi C; Sblattero D; Chiocchetti A; Dianzani U
Am J Clin Exp Immunol; 2012; 1(2):136-46. PubMed ID: 23885320
[TBL] [Abstract][Full Text] [Related]
17. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.
Aricò M; Boggio E; Cetica V; Melensi M; Orilieri E; Clemente N; Cappellano G; Buttini S; Soluri MF; Comi C; Dufour C; Pende D; Dianzani I; Ellis SR; Pagliano S; Marcenaro S; Ramenghi U; Chiocchetti A; Dianzani U
PLoS One; 2013; 8(7):e68045. PubMed ID: 23840885
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
19. OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population.
Jiang Y; Yao M; Liu Q; Zhou C
Arthritis Res Ther; 2013 Jan; 15(1):R3. PubMed ID: 23289928
[TBL] [Abstract][Full Text] [Related]
20. The impact of osteopontin gene variations on multiple sclerosis development and progression.
Comi C; Cappellano G; Chiocchetti A; Orilieri E; Buttini S; Ghezzi L; Galimberti D; Guerini F; Barizzone N; Perla F; Leone M; D'Alfonso S; Caputo D; Scarpini E; Cantello R; Dianzani U
Clin Dev Immunol; 2012; 2012():212893. PubMed ID: 23008732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
